US health officials propose using a cheap antibiotic as a 'morning-after pill' against STDs
- U.S. Health officials plan to endorse doxycycline as a morning-after pill to combat sexually transmitted diseases among gay and bisexual men.
- Doxycycline has shown promising results in reducing the risk of chlamydia, syphilis, and gonorrhea in this group, with a 90% decrease in chlamydia cases.
- The proposed guideline is specific to gay and bisexual men and transgender women at high risk of reinfection, although more research is needed for heterosexual men and women.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left14Leaning Right6Center51Last UpdatedBias Distribution72% Center
